Valuation: ResMed, Inc.

Market Cap 31.64B 28.1B 26.28B 23.95B 45.08B 3,046B 45.7B 318B 123B 1,551B 119B 116B 4,983B P/E 2027 *
19x
P/E 2028 * 17.3x
Enterprise Value 30.68B 27.25B 25.49B 23.22B 43.72B 2,954B 44.33B 308B 119B 1,505B 115B 113B 4,832B EV / Sales 2027 *
5.28x
EV / Sales 2028 * 4.87x
Free-Float
75.13%
Yield 2027 *
1.2%
Yield 2028 * 1.33%
1 day+0.02%
1 week-0.52%
Current month+0.02%
1 month-7.89%
3 months+13.48%
6 months-1.48%
Current year-8.19%
1 week 218.26
Extreme 218.26
224.22
1 month 215.8
Extreme 215.8
237.21
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
284.87
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
293.81
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 28/02/2013
Director of Finance/CFO 40 03/05/2026
Chief Tech/Sci/R&D Officer - 31/01/2024
Director TitleAgeSince
Director/Board Member 78 31/12/2004
Chairman 53 24/01/2023
Chairman 83 31/05/1989
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Exercice

Chief Executive Officer

14,973 0.0104%
02/09/26 Sell

Founder

-970 0.0007%
07/08/26 Exercice

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+0.02%-0.52%-19.21%+49.56% 31.63B
-3.34%-1.92%+34.53%+28.91% 250B
-4.42%-4.42%+6.81%-14.65% 156B
-1.33%+0.74%-10.28%+37.27% 144B
-0.96%-3.12%-55.72%-18.12% 63.26B
-1.31%-1.88%+9.54%+22.96% 49.75B
-3.27%+0.82%+29.86%+49.06% 48.58B
-0.95%+1.10%-18.27%-21.65% 47.99B
-1.23%+4.13%-5.36%+38.57% 46.22B
-3.15%+1.18%+41.93%+55.18% 43.17B
Average -1.99%+1.99%+1.38%+22.71% 87.96B
Weighted average by Cap. -2.54%+2.27%+7.60%+19.74%

Financials

2027 *2028 *
Net sales 5.81B 5.16B 4.82B 4.39B 8.27B 559B 8.39B 58.34B 22.58B 285B 21.8B 21.33B 914B 6.17B 5.48B 5.13B 4.67B 8.79B 594B 8.92B 62.01B 24.01B 303B 23.17B 22.67B 972B
Net income 1.64B 1.46B 1.36B 1.24B 2.34B 158B 2.37B 16.5B 6.39B 80.52B 6.16B 6.03B 259B 1.78B 1.58B 1.48B 1.35B 2.54B 172B 2.57B 17.91B 6.93B 87.4B 6.69B 6.55B 281B
Net Debt -955M -848M -793M -723M -1.36B -91.92B -1.38B -9.59B -3.71B -46.81B -3.58B -3.51B -150B -1.61B -1.43B -1.34B -1.22B -2.3B -155B -2.33B -16.2B -6.27B -79.08B -6.05B -5.92B -254B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
01/10/26 US$221.15 +0.02% 902,520
30/09/26 US$221.10 -0.78% 1,308,167
29/09/26 US$222.83 +0.33% 949,403
28/09/26 US$222.10 +0.05% 862,828
25/09/26 US$222.00 +0.05% 760,793
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
221.15USD
Average target price
250.22USD
Spread / Average Target
+13.15%

Quarterly revenue - Rate of surprise